Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon Read more about Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon
ENTRATA: CB-839 With Everolimus vs. Placebo With Everolimus in Patients With Renal Cell Carcinoma (RCC) Read more about ENTRATA: CB-839 With Everolimus vs. Placebo With Everolimus in Patients With Renal Cell Carcinoma (RCC)
Use of POC Pocket Ultrasound in the Estimation of Left and Right Atrial Pressures Read more about Use of POC Pocket Ultrasound in the Estimation of Left and Right Atrial Pressures
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis Read more about Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Multiple Cardiac Sensors for the Management of Heart Failure Read more about Multiple Cardiac Sensors for the Management of Heart Failure
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC Read more about Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis Read more about An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) Read more about Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05) Read more about Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery Read more about Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery